These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis and in vivo antimalarial activity of novel naphthoquine derivatives with linear/cyclic structured pendants. Tang L, Bei Z, Song Y, Xu L, Wang H, Zhang D, Dou Y, Lv K, Wang H. Future Med Chem; 2017 Jul; 9(11):1117-1127. PubMed ID: 28513196 [Abstract] [Full Text] [Related]
7. Antimalarial effect of agmatine on Plasmodium berghei K173 strain. Su RB, Wei XL, Liu Y, Li J. Acta Pharmacol Sin; 2003 Sep 30; 24(9):918-22. PubMed ID: 12956942 [Abstract] [Full Text] [Related]
11. Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study. Laman M, Benjamin JM, Moore BR, Salib M, Tawat S, Davis WA, Siba PM, Robinson LJ, Davis TM. Malar J; 2015 Mar 21; 14():121. PubMed ID: 25889150 [Abstract] [Full Text] [Related]
12. Update on the in vivo tolerance and in vitro reduced susceptibility to the antimalarial lumefantrine. Nzila A, Okombo J, Ohuma E, Al-Thukair A. J Antimicrob Chemother; 2012 Oct 21; 67(10):2309-15. PubMed ID: 22761327 [Abstract] [Full Text] [Related]
13. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia. Aponte S, Guerra ÁP, Álvarez-Larrotta C, Bernal SD, Restrepo C, González C, Yasnot MF, Knudson-Ospina A. Trans R Soc Trop Med Hyg; 2017 Feb 01; 111(2):71-80. PubMed ID: 28460112 [Abstract] [Full Text] [Related]
14. In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea. Wong RP, Lautu D, Tavul L, Hackett SL, Siba P, Karunajeewa HA, Ilett KF, Mueller I, Davis TM. Trop Med Int Health; 2010 Mar 01; 15(3):342-9. PubMed ID: 20070627 [Abstract] [Full Text] [Related]
15. Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance. Nnamani PO, Ugwu AA, Ibezim EC, Kenechukwu FC, Akpa PA, Ogbonna JN, Obitte NC, Odo AN, Windbergs M, Lehr CM, Attama AA. Int J Nanomedicine; 2016 Mar 01; 11():6365-6378. PubMed ID: 27932882 [Abstract] [Full Text] [Related]